시장보고서
상품코드
1429613

세계의 방사성 의약품 시장 보고서(2024년)

Radiopharmaceuticals Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

방사성 의약품 시장 규모는 향후 몇 년동안 빠르게 성장할 것으로 예상됩니다. 2028년에는 11.8%의 연평균 복합 성장률(CAGR)로 105억 9,000만 달러 규모에 달할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 노인 인구 증가, 암 및 심혈관 질환의 유병률 증가, 대규모 설비 투자, 신제품 출시 등의 요인에 기인하는 것으로 보입니다. 이 기간 동안 주목할 만한 동향으로는 수익과 제품 품질 향상을 위한 타사와의 협력, 수요 증가에 대응하기 위한 공장 생산 능력 확대 투자, 새로운 요구사항에 대응하기 위한 신기술 도입, 비용 절감을 위한 3D 프린팅 기술 도입, 다음과 같은 혁신에 대한 투자 등이 있습니다. 혁신에 대한 투자 등을 들 수 있습니다. 치료학 분야에서의 리더십 추구, 보다 합리적이고 과학적인 접근을 위한 비실리콘 모델링의 모색, AI를 활용하여 R&D 비용을 절감하고 의약품 개발을 촉진하기 위한 AI 활용, 수익 증대를 위한 심장 질환에 초점을 맞춘 기술에 대한 투자 등이 있습니다. 또한, 암을 정확하고 적시에 진단하기 위해 질병에 특화된 접근 방식을 채택하는 것은 주목할 만한 추세입니다.

암과 심혈관 질환의 발병률 증가는 방사성의약품 시장의 원동력이 될 것으로 예상됩니다. 방사성의약품은 기존 의약품을 대체할 수 있는 안전하고 효과적인 치료법으로 점점 더 많이 인식되고 있습니다. 이들은 주로 표적 치료의 장점으로 인해 암 및 심혈관 질환의 치료에서 방사선과 의사에게 뚜렷한 이점을 제공합니다. 암은 전 세계 사망자 6명 중 1명이 암으로 인한 사망으로 사망원인 2위를 차지하고 있습니다. 국제암연구소(IARC)에 따르면, 인구 증가와 고령화로 인해 2040년까지 전 세계 암 발병 건수는 2,750만 건, 암으로 인한 사망자 수는 1,630만 명에 달할 것으로 예측했습니다. 주목할 만한 점은 암으로 인한 사망의 약 70%가 저소득 및 중산층 국가에서 발생한다는 점입니다. 따라서 암과 심혈관 질환의 유병률 증가로 인해 이들 질환의 치료에 방사성의약품에 대한 수요가 증가할 것으로 예상됩니다.

방사성의약품 시장은 맞춤의료에 대한 수요 증가로 인해 큰 폭의 성장이 예상되고 있습니다. 정밀의료라고도 불리는 맞춤의료는 각 환자의 고유한 특성에 맞게 의료 결정, 치료, 개입, 약물요법을 조정하는 혁신적인 의료 접근법입니다. 방사성의약품에 개인맞춤형 의료를 통합하면 영상 처리와 치료의 정확도가 향상되어 의료진이 보다 정밀하고 효과적인 치료를 제공할 수 있게 됩니다. 예를 들어, 2022년 미국 식품의약국 의약품평가연구센터(CDER)는 37개의 새로운 분자 실체(NME)를 승인했으며, 이 중 약 34%인 12개가 개인맞춤의료연합(PMC)에 의해 개인맞춤의료로 분류됐습니다. 따라서 맞춤의료에 대한 수요 증가는 방사성의약품 시장 성장의 원동력이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

  • 고인플레이션이 시장에 미치는 영향
  • 우크라이나·러시아 전쟁이 시장에 미치는 영향
  • 시장에 대한 COVID-19의 영향

제5장 세계 시장 규모와 성장

  • 세계의 방사성 의약품 시장 성장 촉진요인과 억제요인
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계의 방사성 의약품 시장 규모 실적과 성장률, 2018-2023년
  • 세계의 방사성 의약품 시장 규모와 성장 예측, 2023-2028년, 2033년

제6장 시장 세분화

  • 세계의 방사성 의약품 시장, 유형별 세분화, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
  • 진단
  • 치료
  • 기타
  • 세계의 방사성 의약품 시장, 용도별 세분화, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
  • 종양학
  • 심장병학
  • 소화기과
  • 신경내분비학
  • 신경내과
  • 신장학
  • 기타
  • 세계의 방사성 의약품 시장, 최종사용자별 세분화, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
  • 병원
  • 외래수술센터(ASC)
  • 진단센터
  • 암 연구
  • 기타

제7장 지역 및 국가별 분석

  • 세계의 방사성 의약품 시장, 지역별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
  • 세계의 방사성 의약품 시장, 국가별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

  • 방사성 의약품 시장 경쟁 구도
  • 방사성 의약품 시장 기업 개요
    • Cardinal Health
    • Curium Pharma
    • Siemens Healthineers AG
    • Novartis AG
    • General Electric Company(GE)

제31장 기타 주요 기업과 혁신 기업

  • IBA Group
  • Bayer AG
  • Lantheus Medical Imaging Inc.
  • Bracco Imaging SpA
  • Eckert &Ziegler
  • Nihon Medi-Physics Co. Ltd.
  • Fujifilm Corporation
  • ANSTO
  • Yantai Dongcheng Pharmaceutical Group Co. Ltd.
  • Bracco Imaging SpA.
  • Canon Inc.
  • China Isotope &Radiation Corporation(CIRC)
  • Alliance Medical
  • Advanced Accelerator Applications
  • JSC Isotope

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 인수합병(M&A)

제35장 향후 전망과 잠재성 분석

제36장 부록

LSH 24.03.08

Radiopharmaceuticals, also known as radioactive medications, are substances used for the diagnosis or treatment of diseases, including cancer, and contain a radioactive material. These medications are employed in various medical procedures to identify specific illnesses or detect medical issues. Patients may receive radiopharmaceuticals through different administration methods, such as injection, oral ingestion, or application into the eye or bladder.

Radiopharmaceuticals can be broadly categorized into diagnostic, therapeutic, and other types. The process of delivering radioactive atoms to targets associated with tumors is known as radiopharmaceutical therapy. These medications find applications in fields such as oncology, cardiology, gastroenterology, neuroendocrinology, neurology, nephrology, and others. Hospitals, ambulatory surgical centers, diagnostic centers, cancer research institutes, and similar healthcare facilities commonly utilize radiopharmaceuticals for various medical purposes.

The radiopharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides radiopharmaceuticals market statistics, including radiopharmaceuticals industry global market size, regional shares, competitors with a radiopharmaceuticals market share, detailed radiopharmaceuticals market segments, market trends and opportunities, and any further data you may need to thrive in the radiopharmaceuticals industry. This radiopharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The radiopharmaceuticals market size has grown steadily in recent years. It will grow from $6.46 billion in 2023 to $6.77 billion in 2024 at a compound annual growth rate (CAGR) of 4.7%. The expansion observed in the historical period can be linked to an increase in healthcare spending, government initiatives, the convenience of treatment, and shifts in lifestyle.

The radiopharmaceuticals market size is expected to see rapid growth in the next few years. It will grow to $10.59 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%. Anticipated growth in the forecast period is attributed to factors such as the increasing geriatric population, a rise in the prevalence of cancer and cardiovascular diseases, substantial capital investments, and the introduction of new products. Notable trends in this period include collaborative efforts with other companies to enhance revenues and product quality, investments in expanding plant capacity to meet growing demand, embracing new technologies to address emerging requirements, incorporating 3D printing technology in manufacturing for cost savings, investment in innovations such as theranostics, striving for category leadership, exploring in silico modeling for a more rational and scientific approach, leveraging AI to reduce research and development costs and expedite drug development, and investing in technologies focused on cardiology to boost revenues. Additionally, adopting disease-specific approaches for accurate and timely diagnosis of cancer is a noteworthy trend.

The escalating prevalence of cancer and cardiovascular diseases is expected to be a driving force for the radiopharmaceuticals market. Radiopharmaceuticals are increasingly recognized as a safe and effective therapeutic alternative to conventional medicines. They offer radiologists a distinct advantage in treating cancer and cardiovascular diseases, primarily due to their targeted therapy benefits. Cancer ranks as the second leading cause of death, with approximately 1 in 6 global deaths attributed to cancer. According to the International Agency for Research on Cancer (IARC), by 2040, the global burden is projected to reach 27.5 million active cancer incidents and 16.3 million cancer deaths, driven by population growth and aging. Notably, around 70% of cancer deaths occur in low- and middle-income countries. As a result, the increasing prevalence of cancer and cardiovascular diseases is expected to fuel the demand for radiopharmaceuticals in treating these conditions.

The radiopharmaceuticals market is anticipated to experience significant growth, driven by the increasing demand for personalized medicine. Personalized medicine, also known as precision medicine, is an innovative approach to medical care that tailors medical decisions, treatments, interventions, and drug therapies to the unique characteristics of each patient. Integrating personalized medicine into radiopharmaceuticals enhances the precision and accuracy of imaging and therapy, enabling healthcare providers to deliver more targeted and effective care. For example, in 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34%, or 12 of them, classified as personalized medicines by the Personalized Medicine Coalition (PMC). The increasing demand for personalized medicine is thus a driving force behind the growth of the radiopharmaceuticals market.

Several companies in the radiopharmaceuticals market are adopting strategic initiatives such as opening new manufacturing facilities and expanding plant capacity, gaining significant popularity. ITM Isotopen Technologien Munchen AG (ITM), for instance, launched a new manufacturing facility in the Munich area to increase the production capacity of high-purity (n.c.a.) Lutetium-177 and no-carrier-added (n.c.a.) Lutetium-177-containing radiopharmaceuticals. This move aims to meet the high demand for quality medical isotopes for precision oncology worldwide.

Major players in the radiopharmaceuticals market are forming partnerships to enhance their market profitability. In June 2023, the University of Pittsburgh Medical Center partnered with PharmaLogic Holdings Corporation to produce new radiopharmaceuticals at a Pittsburgh facility. This collaboration enables patients and professionals in the UPMC vicinity to access innovative diagnostic and therapeutic drugs that are not currently available. The non-exclusive agreement outlines the conversion of experimental radiopharmaceuticals into therapeutically useful medications.

In June 2021, Curium, a France-based nuclear medicine solutions provider, acquired IASON for an undisclosed amount. This acquisition is expected to bolster Curium's presence in Europe for its extensive range of life-saving diagnostic techniques. By expanding its geographic reach, Curium aims to serve clients and patients throughout Austria and Central Europe with its diverse range of medications and future pipeline of novel agents. IASON, based in Austria, specializes in radiopharmaceutical development, manufacturing, and distribution for use in positron-emission tomography (PET).

Major companies operating in the radiopharmaceuticals market report are Cardinal Health, Curium Pharma, Siemens Healthineers AG, Novartis AG, General Electric Company (GE), IBA Group, Bayer AG, Lantheus Medical Imaging Inc., Bracco Imaging S.p.A., Eckert & Ziegler, Nihon Medi-Physics Co. Ltd., Fujifilm Corporation, ANSTO, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Bracco Imaging SpA., Canon Inc., China Isotope & Radiation Corporation (CIRC), Alliance Medical, Advanced Accelerator Applications, JSC Isotope, Pharm-Sintez, Synektik SA, Polatom, RadioMedic sro, UJV Rez, Actinium Pharmaceuticals Inc., Alseres Pharmaceuticals Inc., Avid Radiopharmaceuticals, Fusion Pharmaceuticals, Peregrine Pharmaceuticals Inc., PETNET Solutions Inc., Positron Corporation, Triad Isotopes Inc., Telix Pharmaceuticals, Rosatom, Alliance Medical Group, Hologic Inc., Segami Corporation, Eczacybaþy-Monrol Nuclear Products, NTP Radioisotopes.

North America was the largest region in the global radiopharmaceuticals market in 2023. The Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the radiopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the radiopharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The radiopharmaceuticals market consists of sales of technetium disofenin, technetium lidofenin, and technetium mebrofenin. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Radiopharmaceuticals Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on radiopharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for radiopharmaceuticals? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The radiopharmaceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Diagnostic; Therapeutic
  • 2) By Application: Oncology; Cardiology; Gastroenterology; Neuroendocrinology; Musculoskeletal; Respiratory; Nephrology; Other Applications
  • 3) By End User: Hospitals And Ambulatory Surgical Centers; Diagnostic Centers; Cancer Research Institutes
  • Companies Mentioned: Cardinal Health; Curium Pharma; Siemens Healthineers AG; Novartis AG; General Electric Company (GE)
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Radiopharmaceuticals Market Characteristics

3. Radiopharmaceuticals Market Trends And Strategies

4. Radiopharmaceuticals Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Radiopharmaceuticals Market Size and Growth

  • 5.1. Global Radiopharmaceuticals Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Radiopharmaceuticals Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Radiopharmaceuticals Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Radiopharmaceuticals Market Segmentation

  • 6.1. Global Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Diagnostic
  • Therapeutic
  • Other Types
  • 6.2. Global Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Cardiology
  • Gastroenterology
  • Neuroendocrinnology
  • Neurology
  • Nephrology
  • Other Applications
  • 6.3. Global Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Cancer Research Institutes
  • Other End Users

7. Radiopharmaceuticals Market Regional And Country Analysis

  • 7.1. Global Radiopharmaceuticals Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Radiopharmaceuticals Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Radiopharmaceuticals Market

  • 8.1. Asia-Pacific Radiopharmaceuticals Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Radiopharmaceuticals Market

  • 9.1. China Radiopharmaceuticals Market Overview
  • 9.2. China Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Radiopharmaceuticals Market

  • 10.1. India Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Radiopharmaceuticals Market

  • 11.1. Japan Radiopharmaceuticals Market Overview
  • 11.2. Japan Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Radiopharmaceuticals Market

  • 12.1. Australia Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Radiopharmaceuticals Market

  • 13.1. Indonesia Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Radiopharmaceuticals Market

  • 14.1. South Korea Radiopharmaceuticals Market Overview
  • 14.2. South Korea Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Radiopharmaceuticals Market

  • 15.1. Western Europe Radiopharmaceuticals Market Overview
  • 15.2. Western Europe Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Radiopharmaceuticals Market

  • 16.1. UK Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Radiopharmaceuticals Market

  • 17.1. Germany Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Radiopharmaceuticals Market

  • 18.1. France Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Radiopharmaceuticals Market

  • 19.1. Italy Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Radiopharmaceuticals Market

  • 20.1. Spain Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Radiopharmaceuticals Market

  • 21.1. Eastern Europe Radiopharmaceuticals Market Overview
  • 21.2. Eastern Europe Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Radiopharmaceuticals Market

  • 22.1. Russia Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Radiopharmaceuticals Market

  • 23.1. North America Radiopharmaceuticals Market Overview
  • 23.2. North America Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Radiopharmaceuticals Market

  • 24.1. USA Radiopharmaceuticals Market Overview
  • 24.2. USA Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Radiopharmaceuticals Market

  • 25.1. Canada Radiopharmaceuticals Market Overview
  • 25.2. Canada Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Radiopharmaceuticals Market

  • 26.1. South America Radiopharmaceuticals Market Overview
  • 26.2. South America Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Radiopharmaceuticals Market

  • 27.1. Brazil Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Radiopharmaceuticals Market

  • 28.1. Middle East Radiopharmaceuticals Market Overview
  • 28.2. Middle East Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Radiopharmaceuticals Market

  • 29.1. Africa Radiopharmaceuticals Market Overview
  • 29.2. Africa Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Radiopharmaceuticals Market Competitive Landscape And Company Profiles

  • 30.1. Radiopharmaceuticals Market Competitive Landscape
  • 30.2. Radiopharmaceuticals Market Company Profiles
    • 30.2.1. Cardinal Health
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Curium Pharma
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Siemens Healthineers AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Novartis AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. General Electric Company (GE)
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Radiopharmaceuticals Market Other Major And Innovative Companies

  • 31.1. IBA Group
  • 31.2. Bayer AG
  • 31.3. Lantheus Medical Imaging Inc.
  • 31.4. Bracco Imaging S.p.A.
  • 31.5. Eckert & Ziegler
  • 31.6. Nihon Medi-Physics Co. Ltd.
  • 31.7. Fujifilm Corporation
  • 31.8. ANSTO
  • 31.9. Yantai Dongcheng Pharmaceutical Group Co. Ltd.
  • 31.10. Bracco Imaging SpA.
  • 31.11. Canon Inc.
  • 31.12. China Isotope & Radiation Corporation (CIRC)
  • 31.13. Alliance Medical
  • 31.14. Advanced Accelerator Applications
  • 31.15. JSC Isotope

32. Global Radiopharmaceuticals Market Competitive Benchmarking

33. Global Radiopharmaceuticals Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Radiopharmaceuticals Market

35. Radiopharmaceuticals Market Future Outlook and Potential Analysis

  • 35.1 Radiopharmaceuticals Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Radiopharmaceuticals Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Radiopharmaceuticals Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제